2Seventy Bio Inc
NASDAQ:TSVT
Balance Sheet
Balance Sheet Decomposition
2Seventy Bio Inc
Current Assets | 237.8m |
Cash & Short-Term Investments | 217m |
Receivables | 13.4m |
Other Current Assets | 7.4m |
Non-Current Assets | 327.7m |
Long-Term Investments | 4.8m |
PP&E | 278.1m |
Intangibles | 6.6m |
Other Non-Current Assets | 38.1m |
Current Liabilities | 59.8m |
Accounts Payable | 6m |
Accrued Liabilities | 38.3m |
Other Current Liabilities | 15.4m |
Non-Current Liabilities | 250.3m |
Other Non-Current Liabilities | 250.3m |
Balance Sheet
2Seventy Bio Inc
Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|
Assets | ||||||
Cash & Cash Equivalents |
0
|
0
|
130
|
71
|
75
|
|
Cash Equivalents |
0
|
0
|
130
|
71
|
75
|
|
Short-Term Investments |
0
|
0
|
135
|
195
|
142
|
|
Total Receivables |
7
|
11
|
17
|
21
|
13
|
|
Accounts Receivables |
7
|
11
|
17
|
21
|
13
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
13
|
14
|
10
|
14
|
7
|
|
Total Current Assets |
21
|
25
|
292
|
301
|
238
|
|
PP&E Net |
258
|
261
|
310
|
297
|
278
|
|
PP&E Gross |
258
|
261
|
310
|
297
|
278
|
|
Accumulated Depreciation |
21
|
30
|
40
|
48
|
57
|
|
Intangible Assets |
9
|
6
|
10
|
7
|
7
|
|
Goodwill |
13
|
13
|
12
|
12
|
0
|
|
Long-Term Investments |
0
|
0
|
97
|
1
|
5
|
|
Other Long-Term Assets |
14
|
8
|
39
|
38
|
38
|
|
Other Assets |
13
|
13
|
12
|
12
|
0
|
|
Total Assets |
315
N/A
|
313
-1%
|
760
+143%
|
657
-14%
|
565
-14%
|
|
Liabilities | ||||||
Accounts Payable |
20
|
7
|
6
|
7
|
6
|
|
Accrued Liabilities |
64
|
59
|
65
|
66
|
38
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
19
|
10
|
27
|
7
|
15
|
|
Total Current Liabilities |
103
|
76
|
98
|
80
|
60
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
168
|
162
|
302
|
266
|
250
|
|
Total Liabilities |
271
N/A
|
238
-12%
|
400
+68%
|
346
-13%
|
310
-10%
|
|
Equity | ||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
0
|
0
|
40
|
294
|
511
|
|
Additional Paid In Capital |
0
|
0
|
400
|
607
|
767
|
|
Other Equity |
44
|
75
|
1
|
3
|
0
|
|
Total Equity |
44
N/A
|
75
+71%
|
360
+382%
|
311
-14%
|
255
-18%
|
|
Total Liabilities & Equity |
315
N/A
|
313
-1%
|
760
+143%
|
657
-14%
|
565
-14%
|
|
Shares Outstanding | ||||||
Common Shares Outstanding |
23
|
23
|
24
|
38
|
51
|